May 26, 2016
The Ministry of Health, Labor and Welfare issued a pharmaceutical safety information bulletin on May 24, notifying physicians that pemphigoid has been added to the list of clinically significant adverse drug reactions (ADRs) in the package inserts for dipeptidyl peptidase-4...read more